Name | Value |
---|---|
Revenues | 284.7M |
Cost of Revenue | 97.7M |
Gross Profit | 187.0M |
Operating Expense | 152.0M |
Operating I/L | 35.0M |
Other Income/Expense | 3.1M |
Interest Income | 2.6M |
Pretax | 38.2M |
Income Tax Expense | -16.1M |
Net Income/Loss | 54.2M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.